Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,983,000 | 843,000 | 446,000 | 557,000 | 372,000 |
| Marketable Securities | N/A | N/A | N/A | N/A | 106,000 |
| Receivables | 270,000 | 420,000 | 109,000 | 181,000 | 231,000 |
| Inventories | 208,000 | 181,000 | 101,000 | 65,000 | 121,000 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 12,000 |
| Other current assets | 213,000 | 241,000 | 387,000 | 2,766,000 | 1,402,000 |
| TOTAL | $2,674,000 | $1,685,000 | $1,043,000 | $3,569,000 | $2,244,000 |
| Non-Current Assets | |||||
| PPE Net | 3,255,000 | 3,315,000 | 3,022,000 | 2,821,000 | 6,273,000 |
| Intangibles | 38,000 | 68,000 | 71,000 | 92,000 | 141,000 |
| Other Non-Current Assets | 5,265,000 | 223,000 | 399,000 | 1,829,000 | 1,355,000 |
| TOTAL | $8,558,000 | $3,606,000 | $3,492,000 | $4,742,000 | $7,769,000 |
| Total Assets | $11,232,000 | $5,291,000 | $4,535,000 | $8,311,000 | $10,013,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,000 | 13,000 | 29,000 | 7,000 | 148,000 |
| Accounts payable and accrued liabilities | 216,000 | 329,000 | 113,000 | 127,000 | 134,000 |
| Accrued Expenses | 237,000 | 152,000 | 68,000 | 65,000 | 145,000 |
| TOTAL | $681,000 | $721,000 | $347,000 | $3,051,000 | $1,565,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,075,000 | 1,979,000 | 1,386,000 | 1,069,000 | 4,626,000 |
| Other Non-Current Liabilities | 447,000 | 384,000 | 299,000 | 4,159,000 | 435,000 |
| TOTAL | $7,528,000 | $2,363,000 | $1,685,000 | $5,228,000 | $5,702,000 |
| Total Liabilities | $8,209,000 | $3,084,000 | $2,032,000 | $8,279,000 | $7,267,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 1,000 | 1,000 | N/A | 1,000 |
| Retained earnings | -736,000 | -463,000 | -107,000 | -4,258,000 | -3,196,000 |
| Other shareholders' equity | 420,000 | 55,000 | 11,000 | 4,290,000 | -55,000 |
| TOTAL | $3,023,000 | $2,207,000 | $2,503,000 | $32,000 | $2,746,000 |
| Total Liabilities And Equity | $11,232,000 | $5,291,000 | $4,535,000 | $8,311,000 | $10,013,000 |